JPRN-UMIN000015188已完成4 期
Study on the impact of lanthanum carbonate on FGF23 in chronic kidney disease - CKD-FGF23 Study
Daiko-Sunadabashi Clinic0 个研究点目标入组 100 人开始时间: 2014年10月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Under 20 years old when informed concent Patients who have a contraindication that is shown in the product documents of lanthanum carbonate or calcium carbonate. Pregnant women or women with possibility of pregnancy. Patients who are inadequate by determination of physician in charge
研究者
相似试验
Unknown
4 期
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23Other Nonspecific Abnormal Serum Enzyme LevelsNCT01845090Camillians Saint Mary's Hospital Luodong30
已完成
3 期
Outcome study of Lanthanum Carbonate compared with Calcium carbonate on cardiovascular mortality and morbidity in patients with chronic kidney disease on hemodialysis: Landmark StudyHemodialysis patients with hyperphosphatemiaJPRN-UMIN000006815andmark Study Group2,347
已完成
不适用
The effect of lanthanum carbonate on hyperphosphatemia in chronic kidney disease patients not on dialysis.non-dialysis chronic kidney diseaseJPRN-UMIN000015223Wakayama Medical University140
尚未招募
不适用
Effect of lanthanum carbonate on serum levels of calcification inhibitor fetuin-A in hemodialysis patientsChronic kidney diseaseJPRN-UMIN000010730Department of urology, school of medicine,yamaguchi university50
已完成
不适用
The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney DiseaseMetabolic Bone DiseaseNCT01002872NorthShore University HealthSystem19